Optimization of transcatheter aortic valve implantation therapy

di Barbanti - Costa - Marchese - Tarantini • 2026 • dettagli prodotto

NOVITÀ • spedizione gratuita
normalmente disponibile
per la spedizione in 4-6 giorni lavorativi

da €40,00 a € 38,00

Paga gli acquisti tra 30€ e 2.000€ in 3 rate
senza interessi. Scopri di più

indice del testo

Aggiungi al carrello Lista dei desideri

DESCRIZIONE

As transcatheter aortic valve implantation moved from inoperable and high-risk candidate to intermediate- and low-risk groups, it stopped being an alternative for the frail and became the default treatment for a broader, younger and more active population.
That shift forces the Heart Team to redefine what constitutes a successful procedure. When life expectancy is measured in decades rather than years, relevant endpoints become the durability or the bioprosthesis, unobstructed coronary access, freedom from permanent conduction disturbance and - crucially in a young patient - a preserved strategy for the next valve intervention, which will in all likelihood be needed.
Understood this way, optimization is not a matter of marginal technical refinements. It is the discipline of ensuring every step of the procedure serves the patient’s whole life, not only the hours spent in the catheterization laboratory. This is the premise of the present textbook, which connects the evidence from recent trials with the everyday decisions that determine long-term outcomes.